1) 新庄正宜:ウイルス感染症9)インフルエンザ.小児感染症学(岡部信彦編),診断と治療社,pp393-399, 2007
2) Fiore AE, Shay DK, Broder K, et al:Prevention and control of influenza:recommendations of the Advisory Committee on Immunization Practices(ACIP), 2008. MMWR Recomm Rep 57(RR-7):1-60, 2008
3) 三田村敬子,山崎雅彦,市川正孝,他:インフルエンザ.小児科臨床 61:179-187,2008
4) 原三千丸:イムノクロマト法キットを用いたインフルエンザの迅速診断.インフルエンザ 9:213-219,2008
5) Sugaya N, Tamura D, Yamazaki M, et al:Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis 47:339-345, 2008
6) Kawai N, Ikematsu H, Iwaki N, et al:A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 56:51-57, 2008
7) Sugaya N, Mitamura K, Yamazaki M, et al:Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 44:197-202, 2007
8) Kawai N, Ikematsu H, Iwaki N, et al:A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B:a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 43:439-444, 2006
9) 松本慶蔵,石田篤子,岡野英幸,他:A・B型インフルエンザウイルス感染症患者におけるザナミビル(リレンザ®)のインフルエンザウイルス感受性と下熱効果の検討―2001~2005年の4シーズンにおけるリレンザ®の市販後調査結果より.化学療法の領域 23:293-304,2007
10) Shiraishi, K, Mitamura, K, Sakai-Tagawa Y, et al:High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis 188:57-61, 2003
11) Kiso M, Mitamura K, Sakai-Tagawa Y, et al:Resistant influenza A viruses in children treated with oseltamivir:descriptive study. Lancet 364:759-765, 2004
12) Jackson ML, Nelson JC, Weiss NS, et al:Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people:a population-based, nested case-control study. Lancet 372:398-405, 2008
13) 新庄正宜,佐藤清二,菅谷憲夫,他:小児病棟における,インフルエンザ接触者へのオセルタミビル予防内服効果.感染症誌 78:262-269, 2004
14) 菅谷憲夫:新型インフルエンザワクチンの問題点.インフルエンザ 9:235-238, 2008